CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL

Breast cancer is considered a major and common health problem in both developing and developed countries. The etiology of breast cancer, the most frequent malignancy diagnosed  in women in the western world, has remained unidentified. Chemicals as the  organophosphorous pesticide malathion have been...

Full description

Bibliographic Details
Main Author: G. M. Calaf
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2018-09-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/809
_version_ 1826563731997327360
author G. M. Calaf
author_facet G. M. Calaf
author_sort G. M. Calaf
collection DOAJ
description Breast cancer is considered a major and common health problem in both developing and developed countries. The etiology of breast cancer, the most frequent malignancy diagnosed  in women in the western world, has remained unidentified. Chemicals as the  organophosphorous pesticide malathion have been used to control a wide range of sucking  and chewing pests of field crops, and are involved in the etiology of breast cancers. The  association between breast cancer initiation and prolonged exposure to estrogen suggests  that this hormone may also have an etiologic role in such a process. However, the key  factors behind the initiation of breast cancer remain to be elucidated. The effect of  environmental substances, such as malathion and estrogen was analyzed in an experimental rat mammary gland model. Different cytoplasmic proteins are key in the transformation of a  normal cell to a malignant tumor cell and among these are the Ras super family and Ras  homologous A (Rho-A). Both types of proteins were greater in animals treated with  malathion than those with estrogens. E-Cadherins constitute a large family of cell surface  proteins.Results showed greater expression of E-Cadherin and vimentin than c-Ha-ras and Rho-A in  rats treated by estrogens. In breast cancer, analysis using immunohistochemical markers is  an essential component of routine pathological examinations, and plays an important role in  the management of the disease by providing diagnostic and prognostic strategies.The aim of the present study was to identify markers that can be used as a prognostic tool for breast cancer patients.
first_indexed 2024-04-10T01:53:18Z
format Article
id doaj.art-6e7b3604190842c596971760ec3153ad
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2025-03-14T10:08:38Z
publishDate 2018-09-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-6e7b3604190842c596971760ec3153ad2025-03-02T11:16:10ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682018-09-0117451310.21294/1814-4861-2018-17-4-5-13555CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODELG. M. Calaf0Instituto de Alta Investigación, Universidad de Tarapaca Center for Radiological Research, Columbia University Medical CenterBreast cancer is considered a major and common health problem in both developing and developed countries. The etiology of breast cancer, the most frequent malignancy diagnosed  in women in the western world, has remained unidentified. Chemicals as the  organophosphorous pesticide malathion have been used to control a wide range of sucking  and chewing pests of field crops, and are involved in the etiology of breast cancers. The  association between breast cancer initiation and prolonged exposure to estrogen suggests  that this hormone may also have an etiologic role in such a process. However, the key  factors behind the initiation of breast cancer remain to be elucidated. The effect of  environmental substances, such as malathion and estrogen was analyzed in an experimental rat mammary gland model. Different cytoplasmic proteins are key in the transformation of a  normal cell to a malignant tumor cell and among these are the Ras super family and Ras  homologous A (Rho-A). Both types of proteins were greater in animals treated with  malathion than those with estrogens. E-Cadherins constitute a large family of cell surface  proteins.Results showed greater expression of E-Cadherin and vimentin than c-Ha-ras and Rho-A in  rats treated by estrogens. In breast cancer, analysis using immunohistochemical markers is  an essential component of routine pathological examinations, and plays an important role in  the management of the disease by providing diagnostic and prognostic strategies.The aim of the present study was to identify markers that can be used as a prognostic tool for breast cancer patients.https://www.siboncoj.ru/jour/article/view/809carcinogenesisratmammary glandmalathionestrogenetiologyproteins
spellingShingle G. M. Calaf
CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
Сибирский онкологический журнал
carcinogenesis
rat
mammary gland
malathion
estrogen
etiology
proteins
title CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
title_full CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
title_fullStr CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
title_full_unstemmed CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
title_short CARCINOGENICITY OF MALATHION AND ESTROGEN IN AN EXPERIMENTAL RAT MAMMARY GLAND MODEL
title_sort carcinogenicity of malathion and estrogen in an experimental rat mammary gland model
topic carcinogenesis
rat
mammary gland
malathion
estrogen
etiology
proteins
url https://www.siboncoj.ru/jour/article/view/809
work_keys_str_mv AT gmcalaf carcinogenicityofmalathionandestrogeninanexperimentalratmammaryglandmodel